US5643944AExpiredUtility

Ovulation control by regulating nitric oxide levels

69
Assignee: UNIV TEXASPriority: Dec 10, 1993Filed: Jun 7, 1995Granted: Jul 1, 1997
Est. expiryDec 10, 2013(expired)· nominal 20-yr term from priority
A61K 31/21A61K 31/195A61K 45/06A61K 31/295A61K 31/223A61K 31/26A61K 31/00A61K 31/22A61K 31/198A61K 31/34
69
PatentIndex Score
25
Cited by
12
References
3
Claims

Abstract

The stimulation of ovulation in a female may be achieved by administering a nitric oxide source, optionally in further combination with one or more of clomiphene, a gonadotropin, and an LH-RH agonist.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. A method for inducing ovulation comprising administering L-arginine, sodium nitroprusside, nitroglycerin, isosorbide mononitrate or isosorbide dinitrate to a female in an amount stimulating ovulation. 
     
     
       2. A method for stimulating ovulation comprising: administering 10-100 mg of isosorbide mononitrate or isosorbide dinitrate to a female.   
     
     
       3. A method for stimulating ovulation comprising: administering an inducer of nitric oxide production selected from the group consisting of L-arginine, sodium nitroprusside, nitroglycerin, isosorbide mononitrate and isosorbide dinitrate; and administering a therapeutically effective amount of leuprolide acetate, wherein the therapeutically effective amount is about 1-10 mg/day.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.